Concordia expands its sustainable biomanufacturing capacity with new CFI investment

-

The funding strengthens the university’s integrated facilities, supporting faster development of greener chemicals, medicines and sustainable bioproducts

Concordia has expanded its sustainable biomanufacturing capacities with upgrades to its Genome Foundry and Bioprocessing facilities, thanks to a $5 million Canada Foundation for Innovation (CFI) Innovation Fund investment — funded 40% by the CFI, with matching funds from Quebec’s Ministry of Higher Education (MES).

The enhancements position Concordia as one of Canada’s leading centres for synthetic biology and bioprocessing. They also strengthen the university’s capacity to develop bio-based products from start to finish — from designing microbial and mammalian cells to testing and refining new medicines and chemicals traditionally sourced from non-sustainable processes.




“These upgraded facilities will allow researchers and partners to move faster, test more ideas and scale promising technologies into real-world applications.


Practical benefits for Canadians

Concordia’s biomanufacturing facilities help create greener chemicals, bioplastics, sustainable biofuels, plant-friendly microbes, alternative proteins and new medicines. They also support efforts to cut greenhouse gas emissions, turn waste into valuable materials and develop affordable, sustainable foods and therapeutics.


By giving small- and medium-sized enterprises, academic partners and government collaborators access to this advanced infrastructure, the expanded facilities will also strengthen national research capacity. This access shortens the path from discovery to market and supports high-skilled jobs.


Researchers at Concordia are now able to bring promising innovations from concept to pilot under one roof. These capabilities help reduce reliance on petrochemicals, limit waste and create scalable technologies that can benefit Canadians and global markets alike.


Strengthening national research infrastructure

Founded in 2016 with a CFI grant, the Genome Foundry has evolved from Canada’s first automated DNA design and assembly facility into a national hub for synthetic biology.

In 2018-2019, the Foundry expanded into mammalian cell engineering through a collaboration with the National Research Council of Canada, which included a foundational investment of $2.4 million through the Cell and Gene Therapy Challenge program to set up the high throughput mammalian genome foundry.


Between 2020 and 2022, bioprocessing capacity was added to link strain engineering the process of modifying microbes like bacteria, yeast and fungi to produce useful products or perform new functions with fermentation and purification.


source : Concordia University

Comments

Post a Comment

Popular posts from this blog

ENVALIOR ANNOUNCES NEW PPS COMPOUNDING FACILITY IN EUROPE

-
Image
Envalior launches new PPS compounding facility in Uerdingen, Germany. New facility supports growing demand for Xytron™ in Europe and the Americas. To better serve growing customer demand in Europe and the Americas, Envalior – a global leader in sustainable and high-performance engineering materials – announces that it will invest in a PPS (Polyphenylene Sulfide) compounding facility in Europe. Envalior’s PPS material Xytron™ combines a strong set of properties, including excellent chemical and hydrolysis resistance at elevated temperatures, extremely stable heat aging performance up to 240°C, very good and stable electrical properties at elevated temperatures, low moisture absorption with high dimensional stability, and inherent flame retardance that meets UL94 V0.  Since 2016, when Xytron™ entered the market, the PPS material has built a strong track record across OEMs and tier customers. The new facility will provide local supply and additional services to customers in Europe whi...
Read more

Today's KNOWLEDGE Share : What Is Going Wrong in UK Plastics Recycling?

-
Image
Today's KNOWLEDGE Share What Is Going Wrong in UK Plastics Recycling? Biffa shut its Sunderland plant. Viridor walked away from Avonmouth and Rochester. Yes Recycling Fife collapsed within a year. All three were backed by major investments All three had buyers lined up for recyclate All three are now offline This is not bad luck It is bad structure Over the next four posts I will break down: 1. Why cheap virgin imports are undercutting UK recyclers 2. How weak policy enforcement is fuelling market failure 3. What volatile PRNs and cheap exports are doing to infrastructure 4. Why demand from brands is softer than their promises Let’s start with the first: **Cheap Virgin Resin = Broken Economics** Virgin PE, PP, and PET have been flooding the global market. New capacity in Asia and the US has driven prices down 30 to 40 percent. Meanwhile, recycled plastic costs more to produce in the UK than it can sell for. We are asking UK recyclers to compete with materials made in places with – ...
Read more

Today's KNOWLEDGE Share : Robotic 3D printing can compete with traditional boatbuilding

-
Image
Today's KNOWLEDGE Share “Robotic 3D printing can compete with traditional boatbuilding”, Simone Barbera and Mattia De Santis, Caracol V2 catamaran was printed in Italy at Caracol’s production center and headquarter in Barlassina, near Milan, with a Heron AM 400, Caracol’s robotic Large Format Additive Manufacturing (LFAM) platform. The lattest was specifically configured with a 7-axis robotic arm mounted on a rail, enabling the printing of parts up to 10 meters in length. How did the collaboration between V2 Group and Caracol come about? Simone Barbera : The collaboration between V2 Group and Caracol originated from a shared vision to revolutionize boat manufacturing through sustainable innovation. V2 Group, a Spanish-company specialized in nautical design and engineering, is seeking to develop electric vessels manufactured sustainably. On the other hand, Caracol, leader in robotic advanced manufacturing technology, had had years of experience working with Large Format Additive Ma...
Read more